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Objective. The aim of the study was to estimate the impact of whole-body cryotherapy (WBC) and subsequent kinesiotherapy on
oxidative stress and lipid profile when performed in a closed cryochamber on healthy subjects.Material and Methods. The effect of
ten WBC procedures lasting 3 minutes a day followed by a 60-minute session kinesiotherapy on oxidative stress and lipid profile in
healthy subjects (WBC group, n = 16) was investigated. The WBC group was compared to the kinesiotherapy only (KT; n = 16)
group. The routine parameters of oxidative stress (antioxidant enzymatic and nonenzymatic antioxidant status, lipid
peroxidation products, total oxidative status (TOS), and oxidative stress index (OSI)) and lipid profile were estimated one day
before the beginning and one day after the completion of the research program. Results. After treatment, in the WBC group, a
significant decrease of oxidative stress markers (TOS and OSI) and a significant increase of total antioxidant capacity were
observed. The activity of plasma SOD-Mn and erythrocyte total SOD increased significantly in the WBC group. In the KT
group, the erythrocyte activity of total SOD, CAT, and GR decreased significantly after the treatment. The levels of T-Chol and
LDL-Chol decreased significantly after treatment in both groups, but the observed decrease of these lipid parameters in the
WBC group was higher in comparison to the KT group. The level of TG decreased significantly after treatment in the WBC
group only. Conclusion. WBC performed in a closed cryochamber followed by kinesiotherapy improves lipid profile and
decreases oxidative stress in healthy subjects.
1. Introduction
Whole-body cryotherapy (WBC) is the therapeutic exposure
of the total human body to extreme cold temperatures
(below -100°C) for a short time (maximum up to 120-180
seconds) [1, 2]. Immediately after each cryotherapy proce-
dure, subjects usually perform an appropriate set of kine-
siotherapy exercises in order to increase and consolidate the
beneficial effects of cryogenic temperature treatment [2].
The action of cryogenic temperatures causes several
favorable physiological reactions such as an analgesic [1–3],
anti-inflammatory [4–6], and the promotion of a circulatory
effect [1, 2]. Cryogenic temperatures applied to the whole
body also improve mood [7] and have a beneficial influence
Hindawi
Oxidative Medicine and Cellular Longevity
Volume 2019, Article ID 7524878, 10 pages
https://doi.org/10.1155/2019/7524878
on the endocrine system [8, 9]. Additionally, the latest
studies show that WBC may improve memory deficits [10],
prooxidant-antioxidant balance [11, 12], lipid profile [13],
and skin appearance [14, 15].
Until now, WBC has been used mainly in sports medi-
cine [16, 17] and in the treatment of locomotor system dis-
eases [18, 19]. Currently, WBC is used more and more
frequently as a wellness method in healthy subjects, to help
maintain good health [2, 20], but the mechanisms of WBC
action are not fully known.
The effect of WBC treatment may depend on the type of
cryochamber in which procedures are performed, the
temperature and number of procedures, and whether WBC
procedures are connected with a subsequent session of kine-
siotherapy [21, 22]. In the available literature, there has been
only one study [13], which estimated the influence of WBC
on lipid profile parameters in healthy subjects, but WBC pro-
cedures were not connected with a subsequent session of
kinesiotherapy, and the authors only estimated lipid profile
parameters. Similarly, there have been a few studies, which
showed a beneficial influence of WBC procedures on the
prooxidant-antioxidant balance in healthy subjects, but they
were performed in different circumstances (type of cryo-
chamber, temperature, without subsequent sessions of kine-
siotherapy), and very often, the authors only estimated the
level of selected parameters of prooxidant-antioxidant bal-
ance. However, evaluation of oxidative stress severity must
be comprised of the determination of oxidative stress
markers as well as the activity of enzymatic and nonenzy-
matic antioxidant systems simultaneously [23, 24]. This is
because disruption of the prooxidative-antioxidative balance
may be caused by increased reactive oxygen species (ROS)
production, impaired ROS elimination, or the combined
effect of both processes [25].
In light of the above findings, the aim of this research was
to assess the influence of WBC, performed in a closed
cryochamber (Wroclawski type) with a subsequent session
of kinesiotherapy, on oxidative stress and lipid profile
simultaneously in healthy subjects. The scheme of whole-
body cryotherapy procedures and estimation of oxidative
stress parameters were similar to the methods used in
our manuscript published earlier [21].
2. Materials and Methods
2.1. Subjects. The research protocol was approved by the
Bioethical Committee of the Medical University of Silesia
in Katowice (permission no. NN-6501-93/I/07), Poland.
All analyzed subjects gave written consent for inclusion
in the research. All investigations were conducted accord-
ing to the Declaration of Helsinki principles (1964).
The research engaged 32 healthy nonsmoking male sub-
jects who were divided randomly by a physician into two
groups with an allocation ratio of 1 : 1 : 16 healthy subjects
exposed to whole-body cryotherapy procedures with subse-
quent kinesiotherapy (WBC group, mean age 46 63 ± 1 5
years) and 16 healthy subjects exposed only to kinesiotherapy
procedures (KT group, mean age 45 94 ± 1 24 years), with no
significant difference in mean age and body mass index
(BMI) between them.
All subjects were healthy volunteers who qualified for a
routine complex treatment called cryorehabilitation includ-
ing WBC (treated as an assisting component) with subse-
quent kinesiotherapy or kinesiotherapy procedures only, in
order to promote and increase wellness. The subjects were
not previously exposed to WBC.
Prior to the research, a resting electrocardiogram was
performed in all the subjects and each subject was examined
by a physician to exclude any coexisting diseases as well as
any contraindications for WBC procedures. Before each
session of WBC, the blood pressure was measured for each
subject [2]. All the subjects were asked to avoid alcohol, any
immunomodulators, immunostimulators, hormones, vita-
mins, minerals, or other substances with antioxidant prop-
erties and drugs for 4 weeks before and during the research.
The diet of the subjects was not modified, although they
were asked to abstain from the consumption of caffeine
12 hours prior to laboratory analyses. They also maintained
the same mode of physical activity during the research. The
demographic characteristics of the healthy subjects are
shown in Table 1.
2.2. Scheme of Whole-Body Cryotherapy and Kinesiotherapy
Procedures. The healthy subjects, depending on the group,
were exposed either to a cycle of WBC procedures lasting 3
minutes a day with a subsequent 60-minute session of kine-
siotherapy or to a 60-minute session of kinesiotherapy only
for 10 consecutive days at the same time in the morning,
excluding the weekend.
The WBC procedures were performed in a closed cryo-
chamber (Wroclawski type) cooled by liquid nitrogen (pro-
duced by Creator, Poland). The cryochamber consisted of
an antechamber with the temperature -60°C and a proper
chamber, where the temperature reached -120°C. The sub-
jects were let into the chamber in groups of four. Each entry
to the cryochamber was preceded by a 30-second adaptation
Table 1: Demographic characteristics of the research subjects.
Characteristic
WBC group
(n = 16)
Kinesiotherapy group
(n = 16) P value
Age, years, mean (SD) 45 75 ± 2 08 46 06 ± 1 44 0.459
Sex (M/F) 16/0 16/0 —
BMI, kg/m2, mean (SD) 23 83 ± 4 5 24 26 ± 6 8 0.957
Smoking (yes/no) 0/16 0/16 —
SD: standard deviation; BMI: body mass index.
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period in the antechamber. After adaptation to cryogenic
temperatures in the antechamber, the subjects entered the
proper chamber for 3 minutes. During the WBC procedure,
all the subjects wore swimsuits, cotton socks, gloves, wooden
shoes, and also dust masks to protect their mouths and noses
and ear-protectors to cover their ears. The subjects were not
allowed to wear jewelry, glasses, and contact lenses. Each sub-
ject was given information concerning the rules of behaviour
in the cryochamber: the need for slow, shallow breathing and
no touching each other while moving about (slow walking in
circles) [20, 21, 26].
Directly after leaving the cryogenic chamber, the subjects
underwent kinesiotherapy lasting for one hour. The program
of kinesiotherapy was the same for all the subjects in both
groups. The program of kinesiotherapy consisted of exercises
on stationary bikes lasting 20 minutes (5min.: 3.5 Rate of
Perceived Exertion (RPE), 4min.: 5 RPE, 2min.: 7 RPE,
4min.: 5 RPE, and 5min.: 3.5 RPE), treadmill (20 minutes
walking at 4.0mph), and whole body stretching exercises
lasting for 20 minutes. All the exercises were carried out
under the supervision of physiotherapists [20]. All the sub-
jects completed the research program, and no complications
or side effects related to the WBC procedures were observed.
A scheme of the study protocol is presented in Figure 1.
2.3. Blood Sample Collection. Two blood samples of all the
subjects were collected in the morning before the first meal:
one on the day before the beginning of the procedure and
the other on the day after completing the research program.
Samples of whole blood (5ml) were collected from the basi-
lic vein into tubes containing ethylenediaminetetraacetic
acid tripotassium salt (Sarstedt, S-Monovette with 1.6mg/ml
EDTA-K3) and into tubes with a clot activator (Sarstedt, S-
Monovette). The blood samples were centrifuged (10min.,
900 g 4°C), and then, the plasma and serum were immedi-
ately separated and stored at a temperature of −75°C, until
biochemical analyses could be performed. The red blood
cells retained from the removal of EDTA-plasma were
rinsed with an isotonic salt solution, and then, 10% of the
hemolysates were prepared for further analyses. Hemoglobin
concentration in the hemolysates was determined by the
standard cyanmethemoglobin method. The inter- and
32 healthy men
Randomization with an
allocation ratio of 1 : 1
Group WBC-16 healthy men Group KT-16 healthy men
One day before the beginning of
therapeutic cycle
Blood sample collection with the
plasma, serum and hemolysates separation
and storage at a temperature of –75°C
A cycle of 10 daily whole-body
cryotherapy procedures lasting
3 minutes with a subsequent
60-minute session of
kinesiotherapy procedures  
A cycle of 10 daily 60-minute
sessions of kinesiotherapy
procedures only
One day aer the completion of
therapeutic cycle
Blood sample collection with the
plasma, serum and hemolysates separation
and storage at a temperature of –75°C
Determination of biochemical parameters
Figure 1: A scheme of the study protocol.
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intra-assay coefficients of variations (CV) were 1.1% and
2.4%, respectively.
2.4. Biochemical Analysis
2.4.1. Determination of Lipid Profile Parameters. Total, HDL,
and LDL cholesterol (T-Chol, HDL-Chol, LDL-Chol) and
triglyceride (TG) concentrations in serum were estimated
using routine techniques (Cobas Integra 400 plus analyzer,
Roche Diagnostics, Mannheim, Germany). The concentra-
tions were expressed in mg/dl. The inter- and intra-assay
coefficients of variations (CV) were, respectively, 2.8% and
5.4% for T-Chol, 3.2% and 5.4% for HDL-Chol, 2.6% and
6.5% for LDL-Chol, and 2.5% and 7.6% for TG.
2.4.2. Oxidative Stress Analysis
(1) Determination of Lipid Peroxidation Products, Total
Oxidative Status, and Oxidative Stress Index. The intensity
of plasma and the erythrocyte lipid peroxidation was mea-
sured spectrofluorimetrically as thiobarbituric acid-reactive
substances (TBARS) according to Ohkawa et al. [27]. The
TBARS concentrations were expressed as malondialdehyde
(MDA) equivalents in μmol/l in plasma or nmol/gHb in
erythrocytes. The inter- and intra-assay coefficients of var-
iations (CV) were 2.1% and 8.3%, respectively.
The total oxidant status (TOS) in serum was determined
with the method described by Erel [28] and expressed in
μmol/l. The inter- and intra-assay coefficients of variations
(CV) were 2.2% and 6.4%, respectively.
The oxidative stress index (OSI), an indicator of the
degree of oxidative stress, was expressed as the ratio of total
oxidant status (TOS) to total antioxidant capacity (FRAP)
in arbitrary units [29].
(2) Determination of Activity of Antioxidant Enzymes. The
activity of superoxide dismutase (SOD, E.C.1.15.1.1) in
plasma and erythrocytes was measured by the Oyanagui
method [30]. Enzymatic activity was expressed in nitrite unit
(NU) in each mg of hemoglobin (Hb) or ml of blood plasma.
One nitrite unit (1NU) means a 50% inhibition of nitrite ion
production by SOD in this method. SOD isoenzymes
(SOD-Mn and SOD-ZnCu) were measured using potas-
sium cyanide as the inhibitor of the SOD-ZnCu isoen-
zyme. The inter- and intra-assay coefficients of variations
(CV) were 2.8% and 5.4%, respectively.
The erythrocyte catalase (CAT, E.C.1.11.1.6.) activity was
assayed by the Aebi [31] kinetic method. It was expressed in
IU/mgHb. The inter- and intra-assay coefficients of varia-
tions (CV) were 2.6% and 6.1%, respectively.
The activity of glutathione peroxidase (GPx,
E.C.1.11.1.9.) in erythrocytes was determined by Paglia and
Valentine’s kinetic method [32], with t-butyl peroxide as a
substrate and expressed as micromoles of NADPH oxidized
per minute and normalized to one gram of hemoglobin
(IU/gHb). The inter- and intra-assay coefficients of varia-
tions (CV) were 3.4% and 7.5%, respectively.
The erythrocyte glutathione reductase (GR, E.C.1.6.4.2)
activity was determined by Richterich’s kinetic method
[33], expressed as micromoles of NADPH utilized per min-
ute and normalized to one gram of hemoglobin (IU/gHb).
The inter- and intra-assay coefficients of variations (CV)
were 2.1% and 5.8%, respectively.
(3) Determination of Nonenzymatic Antioxidant Status. The
total antioxidant capacity of plasma was assayed as the ferric
reducing ability of plasma (FRAP) according to Benzie and
Strain [34] and calibrated using Trolox. It was expressed in
μmol/l. The inter- and intra-assay coefficients of variations
(CV) were 1.1% and 3.8%, respectively.
The concentration of protein sulfhydryl (PSH) was
determined in serum by Koster’s method [35], using dithio-
nitrobenzoic acid (DTNB) and expressed in μmol/l. The
inter- and intra-assay coefficients of variations (CV) were
2.6% and 5.4%, respectively.
The concentration of uric acid (UA) in serum was mea-
sured by a uricase-peroxidase method [36] on the Cobas
Integra 400 plus analyzer and expressed as mg/dl. The inter-
and intra-assay coefficients of variations (CV) were 1.4% and
4.4%, respectively.
2.5. Statistical Analysis. For statistical analysis, the statistical
package of Statistica 10 Pl software was used. For each
parameter, the indicators of descriptive statistics were deter-
mined (mean value and standard deviation (SD)). The nor-
mality of the data distribution was checked using the
Shapiro-Wilk test, while the homogeneity of the variance
was checked by applying Levene’s test. In order to compare
differences between groups, either an independent sample
Student t test was used or, alternatively, the Mann-Whitney
U test. In the case of dependent samples, the Student t test
was used or alternatively the Wilcoxon test. Differences at
the significance level of P < 0 05 were considered as statisti-
cally significant.
3. Results
3.1. Lipid Profile Parameters. Levels of T-Chol and LDL-Chol
decreased significantly after the treatment in both groups,
but the observed decrease of these lipid parameters in the
WBC group was higher in comparison to the KT group. In
turn, in the WBC group, the level of TG decreased signifi-
cantly after the completion of the treatment in comparison
to the KT group. The level of HDL-Chol did not change sig-
nificantly in both groups (Figures 2–5).
3.2. Lipid Peroxidation Products, Total Oxidative Status, and
Oxidative Stress Index. The subjects in the WBC group who
underwent a ten-day long cycle of WBC procedures with
subsequent kinesiotherapy had, after the completion of the
treatment, a statistically significant decrease in plasma
MDA, serum TOS, and value of OSI in comparison to initial
values. The differences of these parameters prior to posttreat-
ment values (Δ) in the WBC group were significantly higher
in comparison to the KT group. The levels of MDA in
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erythrocyte did not change significantly in the WBC group.
In the KT group of subjects who underwent a cycle of only
kinesiotherapy, without previous cryotherapy procedures,
no significant changes in the levels of plasma and erythrocyte
MDA or serum TOS or OSI were observed after the comple-
tion of the treatment, in comparison to the initial values
before the beginning of the kinesiotherapy cycle (Table 2).
3.3. Antioxidant Enzymes. The subjects in the WBC group
had, after the completion of the treatment, a statistically sig-
nificant increase in the plasma activity of SOD-Mn and
erythrocyte total SOD.
However, the activity of plasma total SOD, SOD-CuZn,
and erythrocyte activity of CAT, GPx, and GR did not change
significantly in theWBC group after the treatment. In the KT
group, the erythrocyte activity of total SOD, CAT, and GR, in
contrast to the WBC group, decreased significantly after the
treatment. Additionally, the difference prior to posttreatment
values (Δ) of erythrocyte total SOD activity in the WBC
group was significantly higher as compared to the KT group.
Similarly, as in the WBC group, the activity of plasma total
SOD, SOD-CuZn, and erythrocyte GPx did not change sig-
nificantly in the KT group after the treatment.
Additionally, in the KT group, the activity of plasma
SOD-Mn and SOD-CuZn did not change significantly after
the treatment in comparison to the WBC group (Table 3).
3.4. Nonenzymatic Antioxidant Status. In the WBC group of
subjects who underwent a ten-day long cycle of WBC proce-
dures with subsequent kinesiotherapy, FRAP values
increased significantly after the treatment. After the comple-
tion of the treatment, FRAP values were significantly higher
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Figure 3: Levels of LDL cholesterol (LDL-Chol) (mean value ± standard deviation (SD)) in healthy subjects before and after the completion of
a cycle of ten whole-body cryotherapy procedures with subsequent kinesiotherapy (WBC group) or a cycle of ten kinesiotherapy procedures
only (KT group), with statistical analyses. (s): serum; Δ: difference prior to posttreatment.
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Figure 2: Levels of total cholesterol (T-Chol) (mean value ± standard deviation (SD)) in healthy subjects before and after the completion of a
cycle of ten whole-body cryotherapy procedures with subsequent kinesiotherapy (WBC group) or a cycle of ten kinesiotherapy procedures
only (KT group), with statistical analyses. (s): serum; Δ: difference prior to posttreatment.
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in the WBC group when compared to the KT group. Simi-
larly, the difference of this parameter prior to posttreatment
values (Δ) in theWBC group was significantly higher in com-
parison to the KT group. The level of PSH and UA in the
WBC group of subjects did not change significantly after
the treatment. However, FRP values as well as PSH and UA
concentration did not change significantly in the KT group
of patients who underwent a cycle of kinesiotherapy only,
without previous cryotherapy procedures (Table 4).
4. Discussion
Only a few papers have estimated the impact ofWBC on lipid
profile parameters. In experimental model animals (rats)
who were exposed to WBC for 5 or 10 days, HDL and LDL
cholesterol fraction decreased and total cholesterol levels in
animals subjected to -60°C sessions for 10 days remained
unchanged [37]. However, in the available literature so far,
there has been only one paper on the effect of WBC on lipid
profile in healthy subjects. Lubkowska et al. [13] reported
reducing T-Ch, LDL-Ch, and TG levels and increasing
HDL-Ch level after 20 sessions of WBC in healthy men, but
after 10 sessions of WBC only, the LDL-Ch level decreased
together with an observed HDL-Ch level increase in healthy
men (cryogenic temperature -130°C, liquid nitrogen, without
kinesiotherapy procedures). In another paper by these
authors [38], in obese subjects without diet modification, a
significant decrease in the level of LDL-Ch and TG was
observed with a slight increase in the HDL-Ch level after
WBC treatment (temperature -120°C, 2-3 minutes, the type
of cryochamber not given), including two cryotherapy treat-
ments of 20 daily sessions in the second and the last month of
152.3
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Figure 5: Levels of triglycerides (TG) (mean value ± standard deviation (SD)) in healthy subjects before and after the completion of a cycle of
ten whole-body cryotherapy procedures with subsequent kinesiotherapy (WBC group) or a cycle of ten kinesiotherapy procedures only (KT
group), with statistical analyses. (s): serum; Δ: difference prior to posttreatment.
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Figure 4: Levels of HDL cholesterol (HDL-Chol) (mean value ± standard deviation (SD)) in healthy subjects before and after the completion
of a cycle of ten whole-body cryotherapy procedures with subsequent kinesiotherapy (WBC group) or a cycle of ten kinesiotherapy
procedures only (KT group), with statistical analyses. (s): serum; Δ: difference prior to posttreatment.
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intervention. In our study, we observed a significant decrease
in T-Chol, LDL-Ch, and TG levels after a ten-day long cycle
of WBC procedures with subsequent kinesiotherapy in
healthy subjects. The HDL-Ch level did not change signifi-
cantly in the present study in the WBC group after the com-
pletion of the treatment.
So far, there have not been many reports on the impact of
WBC procedures performed in different cryochambers on
the prooxidant-antioxidant balance in healthy subjects.
In their study, Dugue et al. [39] observed a significant
increase in the value of total peroxyl radical-trapping antiox-
idant capacity of plasma (TRAP) 2 minutes after cold stress
in the first 4 weeks of their study. Thirty-five minutes after
application of WBC, the values of TRAP did not vary from
baseline values. But after 4 weeks, no changes in TRAP values
after the WBC were noticed and no long-term changes in
basal TRAP values were observed (temperature: -110°C, time:
2 minutes, coolant liquid nitrogen, 3 times per week for 12
weeks, without subsequent kinesiotherapy).
In the study of Lubkowska et al. [40], healthy men were
exposed to a single WBC session (temperature: −130°C, time:
3 minutes, closed cryochamber, liquid nitrogen coolant)
without subsequent kinesiotherapy. A significant increase in
GPx and GR activities, with a simultaneous decrease in
CAT and glutathione S-transferase activities, was observed.
A significant increase in the concentration of glutathione,
uric acid, albumins, and extraerythrocyte hemoglobin was
also observed in the serum of the subjects. The level of TOS
did not change after WBC procedure. The authors concluded
that a single stimulation with cryogenic temperatures results
in oxidative stress in a healthy body, but the level of this stress
is not very high.
However, Mila-Kierzenkowska et al. [41] showed that
even a single application of cryotherapy prior to exercise
may have a beneficial impact on the antioxidant system of
the body and alleviates signs of exercise-induced oxidative
Table 2: Levels of lipid peroxidation parameters, total oxidative
status (TOS), and oxidative stress index (OSI)
(mean value ± standard deviation (SD)) in healthy subjects before
and after the completion of a cycle of ten whole-body cryotherapy
procedures with subsequent kinesiotherapy (WBC group) or a
cycle of ten kinesiotherapy procedures only (KT group), with
statistical analyses.
Parameters WBC group KT group P
MDA (p)
(μmol/l)
Before 2 08 ± 0 47 2 30 ± 0 52 0.227
After 1 63 ± 0 35 2 39 ± 0 52 <0.001
P∗ 0.013 0.569
Δ −0 45 ± 0 61 0 09 ± 0 70 0.027
MDA (e)
(nmol/gHb)
Before 0 13 ± 0 01 0 17 ± 0 03 <0.001
After 0 13 ± 0 01 0 17 ± 0 05 0.010
P∗ 0.234 0.999
Δ 0 00 ± 0 01 0 00 ± 0 05 0.799
TOS (s)
(μmol/l)
Before 20 69 ± 4 99 10 12 ± 3 28 <0.001
After 15 88 ± 3 77 11 97 ± 6 71 0.053
P∗ 0.006 0.485
Δ −4 81 ± 5 51 1 85 ± 7 80 0.010
OSI (p/s)
(arbitrary unit)
Before 19 51 ± 7 75 6 84 ± 3 03 <0.001
After 9 65 ± 3 18 10 79 ± 9 02 0.637
P∗ <0.001 0.196
Δ −9 87 ± 7 50 3 96 ± 8 73 <0.001
P: statistical significance of differences between both groups of patients; P∗:
statistical significance of differences between values before and after
treatment in particular groups of patients. (p): plasma; (s): serum; (e):
erythrocyte lysates; Δ: difference prior to posttreatment.
Table 3: Activities of antioxidant enzymes
(mean value ± standard deviation (SD)) in healthy subjects before
and after the completion of a cycle of ten whole-body cryotherapy
procedures with subsequent kinesiotherapy (WBC group) or a
cycle of ten kinesiotherapy procedures only (KT group), with
statistical analyses.
Parameters WBC group KT group P
Total SOD (p)
(NU/ml)
Before 9 43 ± 2 77 11 2 ± 1 93 0.050
After 9 40 ± 3 07 11 6 ± 3 26 0.062
P∗ 0.818 0.679
Δ −0 03 ± 4 74 0 40 ± 3 82 0.775
SOD-Mn (p)
(NU/ml)
Before 3 96 ± 2 01 4 50 ± 1 41 0.387
After 5 19 ± 2 05 5 16 ± 2 19 0.964
P∗ 0.030 0.179
Δ 1 23 ± 1 96 0 65 ± 2 00 0.419
SOD-CuZn (p)
(NU/ml)
Before 6 77 ± 2 70 6 72 ± 1 96 0.957
After 4 84 ± 2 05 6 60 ± 2 92 0.060
P∗ 0.063 0.918
Δ −1 93 ± 4 05 −0 12 ± 3 05 0.166
Total SOD (e)
(NU/mgHb)
Before 83 0 ± 9 82 114 0 ± 20 8 <0.001
After 102 0 ± 13 1 98 5 ± 17 4 0.493
P∗ 0.001 0.002
Δ 19 3 ± 13 9 −15 3 ± 12 7 <0.001
CAT (e)
(IU/mgHb)
Before 104 0 ± 15 0 128 0 ± 11 2 0.352
After 112 0 ± 11 2 111 0 ± 15 6 0.242
P∗ 0.179 0.049
Δ 34 4 ± 87 0 39 9 ± 80 0 0.853
GPx (e)
(IU/gHb)
Before 23 1 ± 3 86 23 8 ± 7 20 0.752
After 22 0 ± 4 57 21 2 ± 3 71 0.606
P∗ 0.121 0.179
Δ −1 17 ± 3 31 −2 59 ± 7 99 0.519
GR (e)
(IU/gHb)
Before 1 17 ± 0 37 1 49 ± 0 53 0.056
After 0 99 ± 0 48 1 14 ± 0 61 0.450
P∗ 0.134 0.010
Δ −0 18 ± 0 43 −0 35 ± 0 44 0.267
P: statistical significance of differences between both groups of patients; P∗:
statistical significance of differences between values before and after
treatment in particular groups of subjects. (p): plasma; (e): erythrocyte
lysates; Δ: difference prior to posttreatment.
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stress (a single session of WBC, temperature: -130°C, time: 1-
2min., cryochamber with cold retention, liquid air coolant).
In addition, Miller et al. [42] also observed an increase in
total antioxidant status and the level of UA as a result of a
series of short-term whole-body cryotherapy (10 WBC ses-
sions, temperature: -130°C, time: 3 minutes, without subse-
quent kinesiotherapy) in healthy subjects.
In our research, the WBC group who underwent a ten-
day long cycle of WBC procedures with subsequent kine-
siotherapy had, after the completion of the treatment, a sig-
nificant decrease in plasma MDA, serum TOS, and value of
OSI. This is in comparison to initial values and the KT group
of subjects who underwent a cycle of kinesiotherapy only,
without previous cryotherapy procedures. Additionally, the
subjects in the WBC group had, after the completion of the
treatment, a significant increase in the plasma activity of
SOD-Mn, FRAP values, and erythrocyte total SOD in com-
parison to the KT group. So, a ten-day long cycle of WBC
procedures performed in a closed cryochamber cooled by liq-
uid nitrogen at the temperature of -120°C with subsequent
kinesiotherapy significantly decreased oxidative stress in
healthy subjects.
The observed differences in the results of various
researches may be related to the type of cryochamber
being used and the coolant medium, in addition to the
time and temperature of exposure to WBC as well as sex
and body mass of subjects. Therefore, further studies are
necessary [43].
4.1. Novelty of the Presented Research. In this research, for the
first time, we assessed the influence of WBC, performed in a
closed cryochamber (Wroclawski type) with a subsequent
session of kinesiotherapy, on oxidative stress and lipid
profile parameters, which were estimated simultaneously
in healthy subjects.
There have been a few studies [41, 42], which showed
a beneficial influence of WBC procedures on the
prooxidant-antioxidant balance in healthy subjects, but
they were performed in different circumstances (type of
cryochamber, temperature, without subsequent sessions
of kinesiotherapy), and very often, the authors only esti-
mated the level of selected parameters of prooxidant-
antioxidant balance. In the presented study, we estimated
oxidative stress assessing the parameters of enzymatic
and nonenzymatic antioxidant system as well as parame-
ters of lipid peroxidation, total oxidant status, and oxida-
tive stress index.
Similarly, in the available literature, there has been only
one study [13], which estimated the influence of WBC on
lipid profile parameters in healthy subjects, but WBC
procedures were not connected with a subsequent session
of kinesiotherapy, and the authors only estimated lipid
profile parameters.
The obtained results in this presented study are similar to
our previous research, in which a beneficial impact of ten
WBC procedures performed in a cryochamber with cold
retention followed by kinesiotherapy (temperature: -120°C,
time: 3min, liquid air coolant) on oxidative stress was
observed in healthy subjects [20]. We also observed a similar
influence of WBC procedures performed in closed cryo-
chamber [21] as well as in cryochamber with cold retention
[44] on oxidative stress in patients with ankylosing spondyli-
tis. Additionally, we observed in patients with ankylosing
spondylitis a significant decrease in T-Ch, LDL-Ch, and TG
levels after the completion of ten daily procedures of WBC
treatment (cryochamber with cold retention cooled by syn-
thetic liquid air, temperature: -120°C) followed by kine-
siotherapy [44].
To sum up, for the first time, in our studies, we showed
that WBC performed in closed cryochamber and in cryo-
chamber with cold retention has similar effect on oxidative
stress and lipid profile. It also seems that it does not depend
on the state of health. The obtained results give very impor-
tant information about indications for the use of WBC by
physicians and physiotherapists.
5. General Conclusion
Whole-body cryotherapy procedures performed in a closed
cryochamber (Wroclawski type) followed by kinesiotherapy
decrease lipid profile as well as oxidative stress in healthy
subjects. Whole-body cryotherapy may be a beneficial well-
ness method.
Data Availability
The data used to support the findings of this study are
included within the article.
Table 4: Levels of nonenzymatic antioxidants
(mean value ± standard deviation (SD)) in healthy subjects before
and after the completion of a cycle of ten whole-body cryotherapy
procedures with subsequent kinesiotherapy (WBC group) or a
cycle of ten kinesiotherapy procedures only (KT group), with
statistical analyses.
Parameters WBC group KT group P
FRAP
(μmol/l)
Before 646 1 ± 146 0 639 4 ± 83 8 0.876
After 727 1 ± 114 4 609 9 ± 90 4 0.003
P∗ <0.001 0.088
Δ 81 0 ± 59 6 −29 5 ± 78 9 <0.001
PSH (s)
(μmol/l)
Before 613 2 ± 323 1 481 4 ± 126 8 0.145
After 588 6 ± 312 7 451 4 ± 137 0 0.123
P∗ 0.438 0.087
Δ −24 6 ± 170 1 −30 1 ± 163 2 0.926
UA (s)
(mg/dl)
Before 5 33 ± 1 50 5 61 ± 0 86 0.513
After 5 47 ± 1 26 5 31 ± 1 24 0.720
P∗ 0.352 0.198
Δ 0 15 ± 0 85 −0 30 ± 0 88 0.154
P: statistical significance of differences between both groups of patients; P∗:
statistical significance of differences between values before and after
treatment in particular groups of patients. (p): plasma; (s): serum; Δ:
difference prior to posttreatment.
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